Olov Sterner
81 – 90 of 238
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
(
- Contribution to journal › Article
-
Mark
SAR studies of capsazepinoid bronchodilators 3: The thiourea part (coupling region) and the 2-(4-chlorophenyl)ethyl moiety (C-region).
(
- Contribution to journal › Article
-
Mark
Discovery of a potent and long-acting bronchorelaxing capsazepinoid, RESPIR 4-95
(
- Contribution to journal › Article
-
Mark
Azaflavones compared to flavones as ligands to the benzodiazepine binding site of brain GABA(A) receptors.
(
- Contribution to journal › Article
-
Mark
Affinity of 3-acyl substituted 4-quinolones at the benzodiazepine site of GABAA receptors.
(
- Contribution to journal › Article
-
Mark
Synthesis of biomimetic precursors of isovelleral analogues.
(
- Contribution to journal › Article
-
Mark
Bioactive alkenylphenols from Piper obliquum.
(
- Contribution to journal › Article
-
Mark
SAR studies of capsazepinoid bronchodilators. Part 2: Chlorination and catechol replacement in the A-ring.
(
- Contribution to journal › Article
-
Mark
Imidazo[1,2-a]pyridine derivatives as inhibitors of TNF-alpha expression in T cells
(
- Contribution to journal › Article
-
Mark
SAR studies of capsazepinoid bronchodilators. Part 1: The importance of the catechol moiety and aspects of the B-ring structure.
(
- Contribution to journal › Article